The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-(4-Amino-6-((3-phenylpropyl)amino)-1,3,5-triazin-2-yl)-4-chlorophenyl)methanol ID: ALA4465512
PubChem CID: 155531067
Max Phase: Preclinical
Molecular Formula: C19H20ClN5O
Molecular Weight: 369.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(NCCCc2ccccc2)nc(-c2cc(Cl)ccc2CO)n1
Standard InChI: InChI=1S/C19H20ClN5O/c20-15-9-8-14(12-26)16(11-15)17-23-18(21)25-19(24-17)22-10-4-7-13-5-2-1-3-6-13/h1-3,5-6,8-9,11,26H,4,7,10,12H2,(H3,21,22,23,24,25)
Standard InChI Key: ITJQCZIUBPLXKZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
33.0412 -4.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0400 -4.8518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7481 -5.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4577 -4.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4549 -4.0287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7463 -3.6234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1580 -3.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8676 -4.0263 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5733 -3.6158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5706 -2.7977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8564 -2.3920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1536 -2.8049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.2823 -4.0220 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9887 -3.6111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8504 -1.5748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7438 -2.8062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0349 -2.3997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6977 -4.0174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4041 -3.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1131 -4.0127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1125 -4.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8207 -5.2361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5280 -4.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5227 -4.0037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8139 -3.6013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7479 -6.0780 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
9 13 1 0
13 14 1 0
11 15 1 0
6 16 1 0
16 17 1 0
14 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
3 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.86Molecular Weight (Monoisotopic): 369.1356AlogP: 3.31#Rotatable Bonds: 7Polar Surface Area: 96.95Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.43CX LogP: 4.41CX LogD: 4.36Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.55Np Likeness Score: -0.91
References 1. Yu X, Huang XP, Kenakin TP, Slocum ST, Chen X, Martini ML, Liu J, Jin J.. (2019) Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68)., 62 (16): [PMID:31298539 ] [10.1021/acs.jmedchem.9b00869 ]